These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9520451)

  • 1. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy.
    Basadonna GP; Auersvald L; Khuong CQ; Zheng XX; Kashio N; Zekzer D; Minozzo M; Qian H; Visser L; Diepstra A; Lazarovits AI; Poppema S; Strom TB; Rothstein DM
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3821-6. PubMed ID: 9520451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies.
    Auersvald LA; Rothstein DM; Oliveira SC; Khuong CQ; Onodera H; Lazarovits AI; Basadonna GP
    Transplantation; 1997 May; 63(9):1355-8. PubMed ID: 9158033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CD45RB antibody deters xenograft rejection by modulating T cell priming and homing.
    Sutherland RM; McKenzie BS; Zhan Y; Corbett AJ; Fox-Marsh A; Georgiou HM; Harrison LC; Lew AM
    Int Immunol; 2002 Aug; 14(8):953-62. PubMed ID: 12147632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB.
    Rayat GR; Gill RG
    Diabetes; 2005 Feb; 54(2):443-51. PubMed ID: 15677502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of simultaneous treatment with 15-deoxyspergualin and monoclonal antibodies to CD45RB and CD154 on murine islet transplantation recipients.
    Jung DY; Lee HJ; Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Lee SK; Joh JW; Kwon GY; Kim SJ
    Transplantation; 2006 Jul; 82(2):188-95. PubMed ID: 16858281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF.
    Parsons RF; Yu M; Vivek K; Zekavat G; Rostami SY; Ziaie AS; Luo Y; Koeberlein B; Redfield RR; Ward CD; Migone TS; Cancro MP; Naji A; Noorchashm H
    Transplantation; 2012 Apr; 93(7):676-85. PubMed ID: 22262127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation.
    Gagliani N; Gregori S; Jofra T; Valle A; Stabilini A; Rothstein DM; Atkinson M; Roncarolo MG; Battaglia M
    PLoS One; 2011; 6(12):e28434. PubMed ID: 22174806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell depletion improves islet allograft survival with anti-CD45RB.
    Lee KM; Yeh H; Zhao G; Wei L; O'Connor M; Stott RT; Soohoo J; Dunussi K; Fiorina P; Deng S; Markmann JF; Kim JI
    Cell Transplant; 2014 Jan; 23(1):51-8. PubMed ID: 23192154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathymic inoculation of donor antigen: an ineffective strategy for prolonging xenograft survival.
    Tran HM; Patel A; Allen RD; O'Connell PJ
    Xenotransplantation; 1999 May; 6(2):147-54. PubMed ID: 10431792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 up-regulation plays a role in tolerance mediated by CD45.
    Fecteau S; Basadonna GP; Freitas A; Ariyan C; Sayegh MH; Rothstein DM
    Nat Immunol; 2001 Jan; 2(1):58-63. PubMed ID: 11135579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.
    Pawlick R; Gala-Lopez B; Pepper AR; Abualhassan N; Bruni A; Suzuki K; Rayat G; Elliott JF; Shapiro AMJ
    Islets; 2017 Jul; 9(4):e1330742. PubMed ID: 28692319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of induction of renal allograft tolerance in CD45RB-treated mice.
    Lazarovits AI; Visser L; Asfar S; LeFeuvre-Haddad CE; Zhong T; Kelvin DJ; Kong C; Khandaker MH; Singh B; White M; Jevnikar AM; Zhang Z; Poppema S
    Kidney Int; 1999 Apr; 55(4):1303-10. PubMed ID: 10200994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
    Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
    J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunosufficient murine model for the study of human islets.
    Zhao G; Moore DJ; Kim JI; Lee KM; O'Connor M; Yang M; Marshall AF; Lei J; Schuetz C; Markmann JF; Deng S
    Xenotransplantation; 2014; 21(6):567-73. PubMed ID: 25041432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo.
    Salvalaggio PR; Camirand G; Ariyan CE; Deng S; Rogozinski L; Basadonna GP; Rothstein DM
    J Immunol; 2006 Feb; 176(4):2292-8. PubMed ID: 16455985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of allograft survival by administration of anti-CD45RB monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-cell proportions.
    Luke PP; Deng JP; Lian D; O'Connell PJ; Garcia B; Jevnikar AM; Zhong R
    Am J Transplant; 2006 Sep; 6(9):2023-34. PubMed ID: 16827791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models.
    Rothstein DM; Livak MF; Kishimoto K; Ariyan C; Qian HY; Fecteau S; Sho M; Deng S; Zheng XX; Sayegh MH; Basadonna GP
    J Immunol; 2001 Jan; 166(1):322-9. PubMed ID: 11123308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.